Guangzhou Excelmab Inc.
Guangzhou Excelmab Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma | CD20-positive Non-Hodgkin Lymphoma | Recruiting | Phase 1 / Phase 2 | 2025-02-27 | NCT06021678 |